Cancer AlteRNAtive Therapy

Download PDF

Recent Publications on Cancer AlteRNAtive Therapy:
An overview of cancer multidrug resistance: a still unsolved problem. Although various mechanisms involved in anticancer multidrug resistance...	27th June, 2008	Charite, Institute of Pathology, Chariteplatz 1, 10117, Berlin, Germany,	Cell Mol Life Sci. 2008 Jun 26;. DOI Direct Link
Facial Transplantation and Immunosuppressed Patients: A New Frontier in Reconstructive Surgery. Composite tissue transplantation in reconstructing complex facial defects...	27th June, 2008	1 Division of Plastic Surgery, Brigham and Women's Hospital, Harvard	Transplantation. 2008 Jun 27;85(12):1693-1697. DOI Direct Link
Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. Somatostatin (SMS), binds to its specific receptors (SSTRs) and transduces...	26th June, 2008	Department of Oncology and Pathology, Karolinska Institute, SE-171 76	Oncol Rep. 2008 Jul;20(1):151-4.
Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: A Best Case Series Program of the National Cancer Institute USA. Although many studies have been conducted on the role of alternative...	26th June, 2008	PBH Research Foundation, Kolkata 700020, West Bengal, India.	Oncol Rep. 2008 Jul;20(1):69-74.
Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield. BACKGROUND: For our clinical immunogene therapy study for the treatment of...	25th June, 2008	Laboratory of Clinical and Tumor Immunology, Erasmus MC-Daniel den Hoed	Cytotherapy. 2008;10(4):406-16. DOI Direct Link
→View more research publications.

BioNews Results for Cancer AlteRNAtive Therapy:
Duke University Medical Center: Combination therapy packs 1-2 punch against melanoma	NewsRX:  Jun 20 2008 11:23PM Matching: cancer alternative therapy
Learn about the World Pain Management Markets	TMC Net:  May 19 2008 8:12PM Matching: cancer alternative therapy
Learn about the World Pain Management Markets	Macro World Investor:  May 19 2008 4:47PM Matching: cancer alternative therapy
Learn about the World Pain Management Markets	Canadian Business Magazine:  May 19 2008 4:15PM Matching: cancer alternative therapy

Cancer AlteRNAtive Therapy Clinical Trials:
Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer	Breast Cancer;   Cancer
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-Based Therapy	Ovarian Cancer;   Cancer of the Fallopian Tube;   Peritoneal Cancer
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer	Adenocarincoma of Pancreas;   Stage III Pancreatic Cancer;   Stage IVA Pancreatic Cancer;   Stage IVB Pancreatic Cancer
Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas	Malignant Glioma
A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.	Neoplasms Intervention: Drug: NM-3
→View more trials.

Cancer AlteRNAtive Therapy Patents:
US Patent No.	Title
5872107	Treatment of urogenital cancer with boron neutron capture therapy
5599796	Treatment of urogenital cancer with boron neutron capture therapy

BioPortfolio Ltd. offers e-mail and postal lists for Cancer AlteRNAtive Therapy scientists - we have details of around 628 individuals working on Cancer AlteRNAtive Therapy .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.